Biomedical (basic)

Ended Definitive Contract Awarded Sep 21, 2000 Last action Jun 13, 2019

Contract number: 00266200009D266005421
Awardee: Leidos, Inc. UEI MDSWM6MB1BH7
Awarding agency: National Institute of Allergy and Infectious Diseases National Institutes of Health, Department of Health and Human Services
Obligated: $69,606,231

Award facts

Contract value 43% obligated: $133,375,743.20 Current, with exercised options

$162,950,791.20 Potential, with all options
Completion date 100% complete: May 17, 2017 Current and potential, with all options
NAICS code: Not on record
PSC: AN11 Health R&D Services; Health Care Services; Basic Research
Set-aside: No set-aside
Competition: Full and Open Competition · 2 offers Negotiated Proposal / Quote
Pricing: Cost Plus Fixed Fee
Place of performance: Frederick, MD 21703, USA

Award details come from SAM.gov/FPDS.

Transactions

Action	Obligated	Date
Funding Only Action P00046	-$94,253	Jun 13, 2019
Funding Only Action 45 · Other function - malaria vaccine production and support services to DE-obligate FY 13 funds line 11 and line 31	-$31,092	Jul 10, 2018
Other Administrative Action 44	-$20,464	May 17, 2017
Other Administrative Action 43	-$79,736	Sep 14, 2016
Supplemental Agreement for work within scope 42	-$218	Jul 23, 2015
Change Order 41	$177,098	May 8, 2014
Supplemental Agreement for work within scope 40	$110,000	Feb 27, 2014
Exercise an Option 39 · Other function - malaria vaccine production and support services	$3,668,476	Sep 12, 2013
Funding Only Action 38 · Other functions - malaria vaccine production and support services	$50,000	Nov 21, 2012
Change Order 37	$4,730,568	Sep 12, 2012
Funding Only Action 36	$1,317,901	Aug 2, 2012
Other Administrative Action 35	$424,131	Jun 1, 2012
Funding Only Action 34	$30,000	Feb 15, 2012
Other Administrative Action 33	$0	Dec 7, 2011
Exercise an Option 32	$6,100,408	Sep 13, 2011
Funding Only Action 31	$1,418,727	Jul 27, 2011
Other Administrative Action 30	$0	Apr 29, 2011
Exercise an Option 29	$5,423,244	Sep 28, 2010
Funding Only Action 28 · Malaria vaccine production and support services	$3,289,380	Sep 16, 2009
Funding Only Action 27	$6,128,493	Sep 29, 2008
Additional Work (new agreement, FAR part 6 applies) 26	$5,412,612	Sep 27, 2007
Other Administrative Action 25	$0	Jun 21, 2007
Other Administrative Action 24	$0	May 18, 2007
Other Administrative Action 23	$0	May 7, 2007
Other Administrative Action 22	$0	Nov 17, 2006
Other Administrative Action 20	$0	Jul 20, 2006
Funding Only Action 21	$3,500,990	Jun 29, 2006
Funding Only Action 19	$500,000	Sep 29, 2005
Funding Only Action 18	$658,038	Sep 26, 2005
Funding Only Action 17	$3,637,980	Mar 22, 2005
Other Administrative Action 16	$0	Oct 26, 2004
Funding Only Action 15	$500,000	Sep 30, 2004
Funding Only Action 14	$3,379,657	May 4, 2004
Supplemental Agreement for work within scope 13	$2,930,447	Sep 24, 2003
Supplemental Agreement for work within scope 12	$1,850,000	Mar 5, 2003
Supplemental Agreement for work within scope 11	$381,571	Sep 30, 2002
Supplemental Agreement for work within scope 10	$0	Feb 26, 2002
Supplemental Agreement for work within scope 9	$0	Nov 13, 2001
Supplemental Agreement for work within scope 8	$0	Nov 9, 2001
Supplemental Agreement for work within scope 7	$2,291,216	Sep 27, 2001
Supplemental Agreement for work within scope 5	$2,121,650	Aug 24, 2001
Supplemental Agreement for work within scope 4	$0	Jun 1, 2001
Supplemental Agreement for work within scope 6	$0	Mar 9, 2001
Supplemental Agreement for work within scope 3	$0	Feb 12, 2001
Supplemental Agreement for work within scope 2	$1,985,074	Sep 26, 2000
Supplemental Agreement for work within scope 1	$3,721,432	Sep 22, 2000
Original award	$4,092,900	Sep 21, 2000

Show all 47

About this award

Written by GovTribe AI · Jan 16, 2025

This is a $162,950,791.20 cost-plus-fixed-fee definitive contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian federal agency, to Leidos, Inc. Research And Development Division. The contract is for biomedical (basic) research and development services, and does not have a set-aside designation.

The contract is associated with larger contract vehicles, including the One Acquisition Solution for Integrated Services (OASIS) and Alliant II Governmentwide Acquisition Contract (GWAC), which enable Leidos to provide integrated professional services across the federal government, including defense, civilian, and health IT solutions. Under these contract vehicles, Leidos has received task orders for a variety of services from agencies such as the Army, Navy, Air Force, DHS, IRS, and HHS.

Quick answers

Who was awarded contract 00266200009D266005421?

00266200009D266005421 was awarded to Leidos, Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on September 21, 2000.

How much is contract 00266200009D266005421 worth?

The government has obligated $69,606,231 on 00266200009D266005421. Its current value, with exercised options, is $133,375,743. Its potential value, with all options, is $162,950,791.

Was contract 00266200009D266005421 competed?

The extent of competition for 00266200009D266005421 was full and open competition. The government received 2 offers.

On GovTribe

See this award's full record

Every transaction and funding action
The awardee's other awards and teaming partners
Similar awards and recompete opportunities
Ask GovTribe AI about this award

Try for free Login